Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Esophagogastric Junction.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01498289
What this trial is testing

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer
SWOG Cancer Research Network 213
Large-scale testing (Phase 3)Study completedNCT03081143
What this trial is testing

Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy

Who this might be right for
Advanced Gastric or EGJ Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 429
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07802288
What this trial is testing

Phase II Study of Trastuzumab Rezetecan Combined With Retlirafusp Alfa With or Without CAPOX as Perioperative Therapy for Resectable Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 80
Testing effectiveness (Phase 2)Ended earlyNCT05207722
What this trial is testing

CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

Who this might be right for
Metastatic HER2 Positive Gastroesophageal Junction Cancer
Celularity Incorporated 1
Testing effectiveness (Phase 2)Ended earlyNCT02016534
What this trial is testing

Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors

Who this might be right for
Stomach Neoplasms
Amgen 60
Testing effectiveness (Phase 2)Looking for participantsNCT07182565
What this trial is testing

Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastroesophageal Junction AdenocarcinomaHypofractionated Radiotherapy
West China Hospital 84
Not applicableNot Yet RecruitingNCT07095699
What this trial is testing

Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled Study

Who this might be right for
Adenocarcinoma of the Esophagogastric Junction
Fudan University 314
Testing effectiveness (Phase 2)Study completedNCT03472365
What this trial is testing

SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 67
Testing effectiveness (Phase 2)Study completedNCT00982592
What this trial is testing

Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the StomachRecurrent Gastric Cancer+4 more
National Cancer Institute (NCI) 124
Testing effectiveness (Phase 2)Study completedNCT02340975
What this trial is testing

A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
MedImmune LLC 114
Testing effectiveness (Phase 2)Study completedNCT02564367
What this trial is testing

Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction

Who this might be right for
Adenocarcinoma,StomachAdenocarcinoma, Esophagogastric Junction
AIO-Studien-gGmbH 30
Testing effectiveness (Phase 2)Study completedNCT02205047
What this trial is testing

Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Malignant Neoplasm of StomachMalignant Neoplasm of Cardio-esophageal Junction of StomachEpidermal Growth Factor Receptor (EGFR) Protein Overexpression
European Organisation for Research and Treatment of Cancer - EORTC 172
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT00601705
What this trial is testing

Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Case Comprehensive Cancer Center 61
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07045805
What this trial is testing

Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric Cancer

Who this might be right for
Gastric Cancer (GC)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 66
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Testing effectiveness (Phase 2)UnknownNCT04781686
What this trial is testing

Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma
Zhou Fuxiang 35
Large-scale testing (Phase 3)Looking for participantsNCT07362186
What this trial is testing

LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
LaNova Medicines Limited 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07817654
What this trial is testing

Trastuzumab Combined With Retlirafusp Alfa in Treating HER2（Human Epidermal Growth Factor Receptor 2） 2+/3+ Gastric/Gastroesophageal Junction Adenocarcinoma After First-line Systemic Therapy Failure

Who this might be right for
GCGEJC
Henan Cancer Hospital 35
Not applicableUnknownNCT05583383
What this trial is testing

The Advanced Adenocarcinoma of Stomach and Gastroesophageal Junction With Camrelizumab+SOX Control Camrelizumab+SOX+ Trastuzumab

Who this might be right for
Advanced Gastric Adenocarcinoma
Henan Cancer Hospital 62
Next Page